XML

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Jul. 31, 2018
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Entity Registrant Name	ATEL Growth Capital Fund 8, LLC
Entity Central Index Key	0001537069
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Units Outstanding		1,612,396

XML

Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
ASSETS
Cash and cash equivalents	$ 357	$ 1,255
Due from affiliate	78	150
Accounts receivable		13
Notes receivable, net	3,125	3,021
Investment in securities	341	243
Warrants, fair value	542	489
Prepaid expenses and other assets	10	4
Total assets	4,453	5,175
Accounts payable and accrued liabilities:
Managing Member	17	56
Accrued distributions to Other Members	248	248
Other	16	1
Total liabilities	281	305
Commitments and contingencies
Members' capital:
Managing Member
Other Members	4,172	4,870
Total Members' capital	4,172	4,870
Total liabilities and Members' capital	$ 4,453	$ 5,175

XML

Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues:
Notes receivable interest income, including accretion of net note origination costs and discounts	$ 132	$ 123	$ 254	$ 267
Gain on early termination of notes receivable				70
Gain on sales or dispositions of investment in securities				1
Unrealized gain (loss) on fair value adjustment for warrants	9	(2)	19	27
Unrealized (loss) gain on fair value adjustment for investment in securities	(43)		98
Other	7	4	10	13
Total revenues	105	125	381	378
Expenses:
Asset management fees to Managing Member	12	14	25	32
Acquisition expense	6	41	33	105
Cost reimbursements to affiliates	32	63	76	135
(Reversal of) provision for credit losses	(9)	(24)	(33)	(24)
Professional fees	9	36	36	57
Outside services	14	19	43	39
Taxes on income and franchise fees	3		3	2
Bank charges	5	5	10	10
Other	7	8	12	15
Total expenses	79	162	205	371
Net income (loss)	26	(37)	176	7
Net income (loss):
Managing Member	38	50	87	99
Other Members	(12)	(87)	89	(92)
Net income (loss)	$ 26	$ (37)	$ 176	$ 7
Net income (loss) per Limited Liability Company Unit (Other Members)	$ (0.01)	$ (0.05)	$ 0.06	$ (0.06)
Weighted average number of Units outstanding	1,612,396	1,615,475	1,612,396	1,616,311

XML

Statements of Changes in Members' Capital - USD ($) $ in Thousands	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Beginning Balance		$ 4,870	$ 7,011	$ 7,011
Repurchase of Units				(30)
Distributions to Other Members	$ (346)	(787)	(888)	(1,774)
Distributions to Managing Member		(87)		(198)
Net (loss) income	$ 26	$ 176	$ 7	(139)
Ending Balance (in Units)	1,612,396	1,612,396
Ending Balance	$ 4,172	$ 4,172		$ 4,870
Other Members [Member]
Beginning Balance (in Units)		1,612,396	1,618,296	1,618,296
Beginning Balance		$ 4,870	$ 7,011	$ 7,011
Repurchase of Units				$ (30)
Repurchase of Units (in Units)				(5,900)
Distributions to Other Members		(787)		$ (1,774)
Net (loss) income		$ 89		$ (337)
Ending Balance (in Units)	1,612,396	1,612,396		1,612,396
Ending Balance	$ 4,172	$ 4,172		$ 4,870
Managing Member [Member]
Beginning Balance
Distributions to Managing Member		(87)		(198)
Net (loss) income		$ 87		$ 198

XML

Statements of Changes in Members' Capital (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Statements of Changes in Members' Capital [Abstract]
Distributions to Other Members, per unit	$ 0.21	$ 0.27	$ 0.49	$ 0.55	$ 1.10

XML

Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Operating activities:
Net income (loss)	$ 26	$ (37)	$ 176	$ 7	$ (139)
Adjustment to reconcile net income (loss) to cash provided by (used in) operating activities:
Accretion of note discount - warrants	(13)	(10)	(24)	(23)
Amortization of net note origination costs	8	3	17	8
Gain on early termination of notes receivable				(70)
Gain on sales or dispositions of investment in securities				(1)
Reversal of provision for credit losses	(9)	(24)	(33)	(24)
Unrealized (gain) loss on fair value adjustment for warrants	(9)	2	(19)	(27)
Unrealized loss (gain) on fair value adjustment for securities	43		(98)
Changes in operating assets and liabilities:
Accounts receivable			13	7
Due from affiliates	(37)	(24)	72	2
Prepaid expenses and other assets	(8)	(2)	(6)	(2)
Accounts payable, Managing Member	(11)		(39)
Accounts payable, other	17		15	(3)
Unearned fee income related to notes receivable	(4)	(4)	(4)	(13)
Net cash provided by (used) in operating activities	3	(96)	70	(139)
Investing activities:
Advance payments			(64)	(56)
Proceeds from early termination of notes receivable				130
Proceeds from sales or dispositions of investment in securities				1
Payments of note origination costs			(2)
Note receivable advances	(416)		(1,016)
Principal payments received on notes receivable	451	554	988	1,334
Net cash provided by (used in) investing activities	35	554	(94)	1,409
Financing activities:
Repurchase of Units		(2)		(18)
Net cash used in financing activities	(384)	(496)	(874)	(1,016)
Net (decrease) increase in cash and cash equivalents	(346)	(38)	(898)	254
Cash and cash equivalents at beginning of period	703	2,152	1,255	1,860	1,860
Cash and cash equivalents at end of period	357	2,114	357	2,114	1,255
Supplemental disclosures of cash flow information:
Cash paid during the period for taxes				3
Other Members [Member]
Operating activities:
Net income (loss)			89		(337)
Financing activities:
Distributions to Members	(346)	(444)	(787)	(888)
Schedule of non-cash investing and financing transactions:
Distributions payable to Members at period-end		250	248	250
Managing Member [Member]
Operating activities:
Net income (loss)			87		$ 198
Financing activities:
Distributions to Members	$ (38)	(50)	(87)	(110)
Schedule of non-cash investing and financing transactions:
Distributions payable to Members at period-end		$ 28	$ 17	$ 28

XML

Organization and Limited Liability Company Matters

6 Months Ended

Jun. 30, 2018

Organization and Limited Liability Company Matters [Abstract]

Organization and Limited Liability Company Matters

1.  Organization and Limited Liability Company matters:

ATEL Growth Capital Fund 8, LLC (the “Company” or the “Fund”) was formed under the laws of the state of California on December 8, 2011 for the purpose of providing financing for the acquisition of equipment and other goods and services used by emerging growth companies and established privately held companies without publicly traded securities, and for providing other forms of financing for, and to acquire equity interests and warrants and rights to purchase equity interests in such companies. The Fund may continue until it is terminated in accordance with the ATEL Growth Capital Fund 8, LLC limited liability company operating agreement dated December 13, 2011 (the “Operating Agreement”). The Managing Member of the Company is AGC Managing Member, LLC (the “Managing Member” or “Manager”), the renamed AGC 8 Managing Member, LLC which was formed in December 2011 as a Nevada limited liability company. Such name change is the result of an amendment to the articles of incorporation filed with the State of Nevada effective March 18, 2014. Contributions in the amount of $500 were received as of December 31, 2011, which represented the initial Member’s capital investment. As a limited liability company, the liability of any individual member for the obligations of the Fund is limited to the extent of capital contributions to the Fund by the individual member.

The offering was terminated on August 20, 2014. Through June 30, 2018, cumulative contributions, net of rescissions and related distributions paid, totaling $16.2 million (inclusive of the $500 initial Member’s capital investment) have been received. As of June 30, 2018, a total of 1,612,396 Units were issued and outstanding.

Prior to the termination of its offering, the Fund, or Managing Member on behalf of the Fund, incurred costs in connection with the organization, registration and issuance of the Units. The amount of such costs borne by the Fund was limited by certain provisions of the Operating Agreement.

These unaudited interim financial statements should be read in conjunction with the financial statements and notes thereto contained in the report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission.

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2018

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2.  Summary of Significant Accounting Policies:

Basis of presentation:

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q as mandated by the Securities and Exchange Commission. The unaudited interim financial statements reflect all adjustments which are, in the opinion of the Managing Member, necessary for a fair statement of financial position and results of operations for the interim periods presented. All such adjustments are of a normal recurring nature. Operating results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the full year.

Certain prior period amounts may have been reclassified to conform to the current period presentation. These reclassifications had no significant effect on the reported financial position or results of operations.

Footnote and tabular amounts are presented in thousands, except as to Units and per Unit data.

In preparing the accompanying financial statements, the Company has reviewed, as determined necessary by the Managing Member, events that have occurred after June 30, 2018, up until the issuance of the financial statements. No events were noted which would require additional disclosure in the footnotes to the financial statements or adjustments thereto.

Cash and cash equivalents:

Cash and cash equivalents include cash in banks and cash equivalent investments such as U.S. Treasury instruments with original and/or purchased maturities of ninety days or less.

Use of estimates:

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. Such estimates primarily relate to the determination of credit losses on notes receivable and the fair valuation of equity securities and warrants.

Segment reporting:

The Company is organized into one operating segment for the purpose of making operating decisions or assessing performance. Accordingly, the Company operates in one reportable operating segment in the United States.

The primary geographic region in which the Company seeks financing opportunities is North America. Currently, 100% of the Company’s operating revenues are from customers domiciled in the United States.

Allowance for Doubtful Accounts

Accounts receivable represent the amounts billed under notes receivable which are currently due to the Company.

Allowances for doubtful accounts are typically established based upon their aging and historical charge off and collection experience and the creditworthiness of specifically identified borrowers, and invoiced amounts. Accounts receivable deemed uncollectible are generally charged off against the allowance on a specific identification basis. Recoveries of amounts that were previously written-off are recorded as other income in the period received.

Accounts receivable are generally placed in a non-accrual status (i.e., no revenue is recognized) when payments are more than 90 days past due. Additionally, management periodically reviews the creditworthiness of companies with note payments outstanding less than 90 days. Based upon management’s judgment, such notes may be placed in non-accrual status. Notes placed on non-accrual status are only returned to an accrual status when the account has been brought current and management believes recovery of the remaining unpaid receivable is probable. All payments received on amounts billed under notes receivable are applied only against outstanding principal balances.

Valuation Adjustments

In addition to the allowance established for delinquent accounts receivable, the total allowance also includes probable impairment charges on notes receivable.

Notes are considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal and/or interest when due according to the contractual terms of the note agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest when due. If it is determined that a loan is impaired with regard to scheduled payments, the Company will perform an analysis of the note to determine if an impairment valuation reserve is necessary. This analysis considers the estimated cash flows from the note, or the collateral value of the property underlying the note when note repayment is collateral dependent. Any required valuation reserve is charged to earnings when determined; and notes are charged off to the allowance as they are deemed uncollectible.

Investment in securities:

From time to time, the Company may purchase securities of its borrowers or receive warrants in connection with its lending arrangements.

Purchased securities

The Company’s purchased securities registered for public sale with readily determinable fair values are measured at fair value with any changes in fair value recognized in the Company’s results of operations. The Company’s purchased securities not registered for public sale that do not have readily determinable fair values are measured at cost minus impairment, and adjusted for changes in observable prices. Factors considered by the Managing Member in determining fair value include, but are not limited to, available financial information, the issuer’s ability to meet its current obligations and indications of the issuer’s subsequent ability to raise capital. As of June 30, 2018 and December 31, 2017, investments in equity securities totaled $341 thousand and $243 thousand, respectively. During the three and six months ended June 30, 2018, the Company recorded fair value adjustments of $43 thousand of unrealized losses and $98 thousand of unrealized gains, respectively. The Company recorded$0 and $1 thousand of gain on sales or disposition of investment in securities during the respective six months ended June 30, 2018 and 2017.

Warrants

Warrants owned by the Company are not registered for public sale, but are considered derivatives and are reflected at an estimated fair value on the balance sheet as determined by the Managing Member. At June 30, 2018 and December 31, 2017, the Managing Member estimated the fair value of warrants to be $542 thousand and $489 thousand, respectively. During the three months ended June 30, 2018 and 2017, the Company recorded unrealized gains of $9 thousand and unrealized losses of$2 thousand, respectively, on the fair valuation of its warrants. During the six months ended June 30, 2018 and 2017, the Company recorded unrealized gains of$19thousand and $27 thousand, respectively, on the fair valuation of its warrants. There were no exercises of warrants during the three and six months ended June 30, 2018 and 2017.

Credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk include cash and cash equivalents, notes receivable and accounts receivable. The Company places the majority of its cash deposits in non-interest bearing accounts with financial institutions that have no less than $10 billion in assets. Such deposits are insured up to $250,000. The remainder of the Funds’ cash is temporarily invested in U.S. Treasury denominated instruments. The concentration of such deposits and temporary cash investments is not deemed to create a significant risk to the Company. Accounts receivable represent amounts due from various industries.

Per Unit data:

The Company issues only one class of Units, none of which are considered dilutive. Net income (loss) per Unit is based upon the weighted average number of Other Members Units outstanding during the period.

Fair value:

Fair value measurements and disclosures are based on a fair value hierarchy as determined by significant inputs used to measure fair value. The three levels of inputs within the fair value hierarchy are defined as follows:

Level 1 – Quoted prices in active markets for identical assets or liabilities. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuations in which all significant inputs are observable in the market.

Level 3 – Valuation is modeled using significant inputs that are unobservable in the market. These unobservable inputs reflect the Company's own estimates of assumptions that market participants would use in pricing the asset or liability.

The Company’s valuation policy is determined by members of the Asset Management, Credit and Accounting departments. Whenever possible, the policy is to obtain quoted market prices in active markets to estimate fair values for recognition and disclosure purposes. Where quoted market prices in active markets are not available, fair values are estimated using discounted cash flow analyses, broker quotes and third party appraisals of collateral and/or other valuation techniques. These techniques are significantly affected by certain of the Company’s assumptions, including discount rates and estimates of future cash flows. Potential taxes and other transaction costs are not considered in estimating fair values. As the Company is responsible for determining fair value, an analysis is performed on prices obtained from third parties. Such analysis is performed by asset management and credit department personnel who are familiar with the Company’s investments in notes receivable and equity securities of venture companies. The analysis may include a periodic review of price fluctuations and validation of numbers obtained from a specific third party by reference to multiple representative sources.

Recent accounting pronouncements:

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2016-15 — Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 addresses specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments in this Update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. This guidance is effective for the Company beginning on January 1, 2018. The adoption of ASU 2016-15 did not have a material impact on its financial statements and disclosures.

In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The main objective of this Update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this Update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018. Management is currently evaluating the standard and expects the Update may potentially result in an increase in the allowance for credit losses given the change to estimated losses over the contractual life adjusted for expected prepayments.

In January 2016, the FASB issued Accounting Standards Update 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The new standard provides guidance related to accounting for equity investments and financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. ASU 2016-01, among other things, (i) requires equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income, (ii) simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment, (iii) eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet, (iv) requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, and (v) requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements. ASU 2016-01 is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. This guidance is effective for the Company beginning on January 1, 2018. The adoption of ASU 2016-01 did have an impact on its financial statements and disclosures.

The Company’s investment securities registered for public sale with readily determinable fair values are measured at fair value with any changes in fair value recognized in the Company's results of operations. The Company elected to record equity investments without readily determinable fair values at cost, less impairment, and adjusted for changes in observable prices. Any changes in the basis of these equity investments are reported in current earnings.

In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. On July 9, 2015, the FASB approved the deferral of the effective date of ASU 2014-09 by one year and in August 2015, issued Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. This guidance is effective for the Company beginning on January 1, 2018. Management’s evaluation of the impact of such adoption on the financial statements of the Fund indicated that such impact was immaterial as the new revenue guideline does not affect revenues from leases and loans, which comprise the majority of the Company’s revenues since leases and loans are not included within the scope of Topic 606.  

XML

Notes Receivable, Net

6 Months Ended

Jun. 30, 2018

Notes Receivable, Net [Abstract]

Notes Receivable, Net

3.  Notes receivable, net:

The Company has various notes receivable from borrowers who have financed the purchase of equipment through the Company. As of June 30, 2018, the original terms of the notes receivable are from 3 to 84 months and bear interest at implicit or stated rates ranging from 4.15% to 18.06% per annum. The notes are secured by the equipment financed and have maturity dates ranging from 2018 through 2021.

At June 30, 2018, the Company had no notes receivable on non-accrual status. As of December 31, 2017, four (Notes A and C) of the Company’s notes receivable were on non-accrual status. Details are as follows, in thousands, except for the number of notes receivable and the annual interest rate:

	Notes receivable A
	December 31, 2017
Number of notes		3
Net investment value	$	33
Annual interest rate		18.00%
Fair value adjustments	$	33
Fair value amount	$	-
Interest income not recorded relative to original terms	$	16

	Note receivable C
	Non-accrual
	December 31, 2017
Number of notes		1
Net investment value	$	17
Annual interest rate		15.88%
Fair value adjustments	$	-
Fair value amount	$	17
Interest income not recorded relative to original terms	$	7

As of June 30, 2018, the minimum future payments receivable are as follows (in thousands):

Six months ending December 31, 2018	$	1,186
Year ending December 31, 2019		1,758
2020		673
2021		187
		3,804
Less: portion representing unearned interest income, net		(591)
		3,213
Unamortized discount on warrants received		(98)
Unamortized initial direct costs		10
Notes receivable, net	$	3,125

XML

Allowance for Credit Losses

6 Months Ended

Jun. 30, 2018

Allowance for Credit Losses [Abstract]

Allowance for Credit Losses

4. Allowance for credit losses:

The Company’s allowance for credit losses are as follows (in thousands):

	Valuation Adjustments - Notes Receivable
Balance December 31, 2016	$	717
Note receivable disposal		(611)
Reversal of provision for credit losses		(73)
Balance December 31, 2017		33
Reversal of provision for credit losses		(33)
Balance June 30, 2018	$	-

The Company’s allowance for credit losses and its recorded investment in notes receivable as of December 31, 2017 were as follows (in thousands):

December 31, 2017		Notes Receivable
Allowance for credit losses:
Ending balance	$	33
Ending balance: individually evaluated for impairment	$	33
Ending balance: collectively evaluated for impairment	$	-
Financing receivables:
Ending balance	$	3,054
Ending balance: individually evaluated for impairment	$	3,054
Ending balance: collectively evaluated for impairment	$	-

The Company evaluates the credit quality of its notes receivables on a scale equivalent to the following quality indicators related to corporate risk profiles:

Pass – Any account whose debtor, co-debtor or any guarantor has a credit rating on publicly traded or privately placed debt issues as rated by Moody’s or S&P for either Senior Unsecured debt, Long Term Issuer rating or Issuer rating that are in the tiers of ratings generally recognized by the investment community as constituting an Investment Grade credit rating; or, has been determined by the Manager to be an Investment Grade Equivalent or High Quality Corporate Credit per its Credit Policy or has a Not Rated internal rating by the Manager and the account is not considered by the Chief Credit Officer of the Manager to fall into one of the three risk profiles below.

Special Mention – Any traditional corporate type account with potential weaknesses (e.g. large net losses or major industry downturns) or, any growth capital account that has less than three months of cash as of the end of the calendar quarter to fund their continuing operations. These accounts deserve management’s close attention. If left uncorrected, those potential weaknesses may result in deterioration of the Fund’s receivable at some future date.

Substandard – Any account that is inadequately protected by the current worth and paying capacity of the borrower or of the collateral pledged, if any. Accounts that are so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Fund will sustain some loss as the likelihood of fully collecting all receivables may be questionable if the deficiencies are not corrected. Such accounts are on the Manager’s Credit Watch List.

Doubtful – Any account where the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Accordingly, an account that is so classified is on the Manager’s Credit Watch List, and has been declared in default and the Manager has repossessed, or is attempting to repossess, the equipment it financed. This category includes impaired notes and leases as applicable.

At June 30, 2018 and December 31, 2017, the Company’s notes receivables by credit quality indicator and by class of financing receivables are as follows (in thousands):

		Notes Receivable
	June 30, 2018		December 31, 2017
Pass	$	3,015	$	2,547
Special mention		8		392
Substandard		102		115
Doubtful		-		-
Total	$	3,125	$	3,054

As of December 31, 2017, the Company’s impaired investment in financing receivables were as follows (in thousands):

	Impaired Investment in Financing Receivables
December 31, 2017	Recorded Investment		Unpaid Principal Balance		Related Allowance		Average Recorded Investment		Interest Income Recognized
With no related allowance recorded
Notes receivable	$	-	$	-	$	-	$	-	$	-
With an allowance recorded
Notes receivable		33		33		33		70		-
Total	$	33	$	33	$	33	$	70	$	-

At June 30, 2018 and December 31, 2017, investment in financing receivables is aged as follows (in thousands):

June 30, 2018		31-60 Days Past Due		61-90 Days Past Due		Greater Than 90 Days		Total Past Due		Current		Total Financing Receivables		Recorded Investment>90 Days and Accruing
Notes receivable	$	-	$	-	$	-	$	-	$	3,125	$	3,125	$	-
Total	$	-	$	-	$	-	$	-	$	3,125	$	3,125	$	-

December 31, 2017		31-60 Days Past Due		61-90 Days Past Due		Greater Than 90 Days		Total Past Due		Current		Total Financing Receivables		Recorded Investment>90 Days and Accruing
Notes receivable	$	-	$	-	$	-	$	-	$	3,054	$	3,054	$	-
Total	$	-	$	-	$	-	$	-	$	3,054	$	3,054	$	-

As of June 30, 2018, the Company had no notes receivable, on non-accrual status. As of December 31, 2017, the Company had four notes receivable on non-accrual status. (See Note 3 for details).

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2018

Related Party Transactions [Abstract]

Related Party Transactions

5.  Related party transactions:

The terms of the Operating Agreement provide that the Managing Member and/or affiliates are entitled to receive certain fees for equipment management and resale and for management of the Company.

The Operating Agreement allows for the reimbursement of costs incurred by the Managing Member and/or affiliates for providing administrative services to the Company. Administrative services provided include Company accounting, investor relations, legal counsel and equipment financing documentation. The Managing Member is not reimbursed for services whereby it is entitled to receive a separate fee as compensation for such services, such as management of investments.

Cost reimbursements to the Managing Member or its affiliates are based on its costs incurred in performing administrative services for the Company. These costs are allocated to each managed entity based on certain criteria such as total assets, number of investors or contributed capital based upon the type of cost incurred. The Managing Member believes that the costs reimbursed are the lower of (i) actual costs incurred on behalf of the Company or (ii) the amount the Company would be required to pay independent parties for comparable administrative services in the same geographic location.

During the three and six months ended June 30, 2018 and 2017, the Managing Member and/or affiliates earned commissions and fees, and billed for reimbursements of costs and expenses pursuant to the Operating Agreement as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Administrative costs reimbursed to Managing Member and/or affiliates	$	32	$	63	$	76	$	135
Asset management fees to Managing Member		12		14		25		32
Acquisition costs and note origination fees paid to Managing Member		6		41		33		105
	$	50	$	118	$	134	$	272

XML

Commitments

6 Months Ended

Jun. 30, 2018

Commitments [Abstract]

Commitments

6.  Commitments:

At June 30, 2018, there were commitments to fund investments in notes receivable totaling $1.2 million. These amounts represent contract awards which may be canceled by the prospective borrower/investee or may not be accepted by the Company.

XML

Members' Capital

6 Months Ended

Jun. 30, 2018

Members' Capital [Abstract]

Members' Capital

7.  Members’ Capital:

A total of 1,612,396 Units were issued and outstanding as of June 30, 2018 and December 31, 2017. The Fund is authorized to issue up to 7,500,000 Units in addition to the Units issued to the initial Member (50 Units).

Distributions to the Other Members for the three and six months ended June 30, 2018 and 2017 are as follows (in thousands, except as to Units and per Unit data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Distributions declared	$	346	$	444	$	787	$	888
Weighted average number of Units outstanding		1,612,396		1,615,475		1,612,396		1,616,311
Weighted average distributions per Unit	$	0.21	$	0.27	$	0.49	$	0.55

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2018

Fair Value Measurements [Abstract]

Fair Value Measurements

 8.  Fair value measurements:

Under applicable accounting standards, fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

At June 30, 2018 and December 31, 2017, the Company’s warrants and investment securities were measured on a recurring basis. At December 31, 2017, only the Company’s warrants were measured on a recurring basis.

The measurement methodology is as follows:

Warrants (recurring)

Warrants owned by the Company are not registered for public sale, but are considered derivatives and are carried on the balance sheet at an estimated fair value at the end of the period. The valuation of the warrants was determined using a Black-Scholes formulation of value based upon the volatility of respective similar publicly traded companies, a risk free interest rate time to maturity, stock prices, exercise prices and number of warrants.

As of June 30, 2018 and December 31, 2017, the calculated fair value of the Fund’s warrant portfolio totaled $542 thousand and $489 thousand, respectively. Such valuation is classified within Level 3 of the valuation hierarchy.

The fair value of warrants that were accounted for on a recurring basis as of the three and six months ended June 30, 2018 and 2017 and classified as level 3 are as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Fair value of warrants at beginning of period	$	521	$	510	$	489	$	481
Fair value of new warrants, recorded during the year   (included as a discount on notes receivable)		12		-		34		-
Unrealized gain (loss) on fair value adjustment for warrants		9		(2)		19		27
Fair value of warrants at end of period	$	542	$	508	$	542	$	508

The following table presents the fair value measurement of impaired assets measured at fair value on a non-recurring basis and the level within the hierarchy in which the fair value measurements fall at December 31, 2017 (in thousands):

	December 31, 2017		Level 1 Estimated Fair Value		Level 2 Estimated Fair Value		Level 3 Estimated Fair Value
Impaired investment securities	$	278	$	-	$	-	$	278

The following tables summarize the valuation techniques and significant unobservable inputs used for the Company’s recurring and non-recurring fair value calculation categorized as Level 3 in the fair value hierarchy at June 30, 2018 and December 31, 2017:

June 30, 2018
	Valuation	Valuation	Unobservable	Range of
Name	Frequency	Technique	Inputs	Input Values
Warrants	Recurring	Black-Scholes formulation	Stock price	$0.00 - $14.75
			Exercise price	$0.01 - $25.76
			Time to maturity (in years)	2.49 - 14.38
			Risk-free interest rate	2.58% - 2.88%
			Annualized volatility	25.13% - 292.22%
December 31, 2017
	Valuation	Valuation	Unobservable	Range of
Name	Frequency	Technique	Inputs	Input Values
Warrants	Recurring	Black-Scholes formulation	Stock price	$0.00 - $14.75
			Exercise price	$0.01 - $25.76
			Time to maturity (in years)	2.99 - 14.88
			Risk-free interest rate	1.98% - 2.49%
			Annualized volatility	27.78% - 83.30%
Impaired Investment Securities	Non-recurring	Market Approach	Qualitative and quantitative information (Investee Management)	Not Applicable

The following disclosure of the estimated fair value of financial instruments is made in accordance with the guidance provided by the Financial Instruments Topic of the FASB Accounting Standards Codification. Fair value estimates, methods and assumptions, set forth below for the Company’s financial instruments, are made solely to comply with the requirements of the Financial Instruments Topic and should be read in conjunction with the Company’s financial statements and related notes.

The Company has determined the estimated fair value amounts by using market information and valuation methodologies that it considers appropriate and consistent with the fair value accounting guidance. Considerable judgment is required to interpret market data to develop the estimates of fair value. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Cash and cash equivalents

The recorded amounts of the Company’s cash and cash equivalents approximate fair value because of the liquidity and short-term maturity of these instruments.

Notes receivable

The fair value of the Company’s notes receivable is generally estimated based upon various methodologies deployed by financial and credit management including, but not limited to, credit analysis, third party appraisal and/or discounted cash flow analysis based upon current market valuation techniques and market rates for similar types of lending arrangements, which may consider adjustments for impaired loans as deemed necessary.

Investment in securities

Investment securities (recurring)

The Company’s investment securities registered for public sale with readily determinable fair values are measured at fair value with any changes in fair value recognized in the Company’s results of operations. The Factors considered by the Managing Member in determining fair value include, but are not limited to, available financial information, the issuer’s ability to meet its current obligations and indications of the issuer’s subsequent ability to raise capital.

The fair value of investment securities that were accounted for on a recurring basis as of the three and six months ended June 30, 2018 and classified as Level 1 are as follows (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2018		2018
Fair value of securities at beginning of period	$	218	$	92
Unrealized (loss) gain on fair value of securities		(42)		84
Fair value of investment securities at end of period	$	176	$	176

The following tables present estimated fair values of the Company’s financial instruments in accordance with the guidance provided by the Financial Instruments Topic of the FASB Accounting Standards Codificationat June 30, 2018 and December 31, 2017 (in thousands):

	June 30, 2018
	Carrying Amount		Level 1		Level 2		Level 3		Total
Financial assets:
Cash and cash equivalents	$	357	$	357	$	-	$	-	$	357
Notes receivable, net		3,125		-		-		3,253		3,253
Investment in securities		176		176		-		-		176
Warrants		542		-		-		542		542
	December 31, 2017
	Carrying Amount		Level 1		Level 2		Level 3		Total
Financial assets:
Cash and cash equivalents	$	1,255	$	1,255	$	-	$	-	$	1,255
Notes receivable, net		3,021		-		-		3,009		3,009
Warrants		489		-		-		489		489

XML

Summary of Significant Accounting Policies (Policy)

6 Months Ended

Jun. 30, 2018

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of presentation:

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q as mandated by the Securities and Exchange Commission. The unaudited interim financial statements reflect all adjustments which are, in the opinion of the Managing Member, necessary for a fair statement of financial position and results of operations for the interim periods presented. All such adjustments are of a normal recurring nature. Operating results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the full year.

Certain prior period amounts may have been reclassified to conform to the current period presentation. These reclassifications had no significant effect on the reported financial position or results of operations.

Footnote and tabular amounts are presented in thousands, except as to Units and per Unit data.

In preparing the accompanying financial statements, the Company has reviewed, as determined necessary by the Managing Member, events that have occurred after June 30, 2018, up until the issuance of the financial statements. No events were noted which would require additional disclosure in the footnotes to the financial statements or adjustments thereto.

Cash and Cash Equivalents

Cash and cash equivalents:

Cash and cash equivalents include cash in banks and cash equivalent investments such as U.S. Treasury instruments with original and/or purchased maturities of ninety days or less.

Use of Estimates

Use of estimates:

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. Such estimates primarily relate to the determination of credit losses on notes receivable and the fair valuation of equity securities and warrants.

Segment Reporting

Segment reporting:

The Company is organized into one operating segment for the purpose of making operating decisions or assessing performance. Accordingly, the Company operates in one reportable operating segment in the United States.

The primary geographic region in which the Company seeks financing opportunities is North America. Currently, 100% of the Company’s operating revenues are from customers domiciled in the United States.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

Accounts receivable represent the amounts billed under notes receivable which are currently due to the Company.

Allowances for doubtful accounts are typically established based upon their aging and historical charge off and collection experience and the creditworthiness of specifically identified borrowers, and invoiced amounts. Accounts receivable deemed uncollectible are generally charged off against the allowance on a specific identification basis. Recoveries of amounts that were previously written-off are recorded as other income in the period received.

Accounts receivable are generally placed in a non-accrual status (i.e., no revenue is recognized) when payments are more than 90 days past due. Additionally, management periodically reviews the creditworthiness of companies with note payments outstanding less than 90 days. Based upon management’s judgment, such notes may be placed in non-accrual status. Notes placed on non-accrual status are only returned to an accrual status when the account has been brought current and management believes recovery of the remaining unpaid receivable is probable. All payments received on amounts billed under notes receivable are applied only against outstanding principal balances.

Valuation Adjustments

Valuation Adjustments

In addition to the allowance established for delinquent accounts receivable, the total allowance also includes probable impairment charges on notes receivable.

Notes are considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal and/or interest when due according to the contractual terms of the note agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest when due. If it is determined that a loan is impaired with regard to scheduled payments, the Company will perform an analysis of the note to determine if an impairment valuation reserve is necessary. This analysis considers the estimated cash flows from the note, or the collateral value of the property underlying the note when note repayment is collateral dependent. Any required valuation reserve is charged to earnings when determined; and notes are charged off to the allowance as they are deemed uncollectible.

Investment in Securities

Investment in securities:

From time to time, the Company may purchase securities of its borrowers or receive warrants in connection with its lending arrangements.

Purchased securities

The Company’s purchased securities registered for public sale with readily determinable fair values are measured at fair value with any changes in fair value recognized in the Company’s results of operations. The Company’s purchased securities not registered for public sale that do not have readily determinable fair values are measured at cost minus impairment, and adjusted for changes in observable prices. Factors considered by the Managing Member in determining fair value include, but are not limited to, available financial information, the issuer’s ability to meet its current obligations and indications of the issuer’s subsequent ability to raise capital. As of June 30, 2018 and December 31, 2017, investments in equity securities totaled $341 thousand and $243 thousand, respectively. During the three and six months ended June 30, 2018, the Company recorded fair value adjustments of $43 thousand of unrealized losses and $98 thousand of unrealized gains, respectively. The Company recorded$0 and $1 thousand of gain on sales or disposition of investment in securities during the respective six months ended June 30, 2018 and 2017.

Warrants

Warrants owned by the Company are not registered for public sale, but are considered derivatives and are reflected at an estimated fair value on the balance sheet as determined by the Managing Member. At June 30, 2018 and December 31, 2017, the Managing Member estimated the fair value of warrants to be $542 thousand and $489 thousand, respectively. During the three months ended June 30, 2018 and 2017, the Company recorded unrealized gains of $9 thousand and unrealized losses of$2 thousand, respectively, on the fair valuation of its warrants. During the six months ended June 30, 2018 and 2017, the Company recorded unrealized gains of$19thousand and $27 thousand, respectively, on the fair valuation of its warrants. There were no exercises of warrants during the three and six months ended June 30, 2018 and 2017.

Credit Risk

Credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk include cash and cash equivalents, notes receivable and accounts receivable. The Company places the majority of its cash deposits in non-interest bearing accounts with financial institutions that have no less than $10 billion in assets. Such deposits are insured up to $250,000. The remainder of the Funds’ cash is temporarily invested in U.S. Treasury denominated instruments. The concentration of such deposits and temporary cash investments is not deemed to create a significant risk to the Company. Accounts receivable represent amounts due from various industries.

Per Unit Data

Per Unit data:

The Company issues only one class of Units, none of which are considered dilutive. Net income (loss) per Unit is based upon the weighted average number of Other Members Units outstanding during the period.

Fair Value

Fair value:

Fair value measurements and disclosures are based on a fair value hierarchy as determined by significant inputs used to measure fair value. The three levels of inputs within the fair value hierarchy are defined as follows:

Level 1 – Quoted prices in active markets for identical assets or liabilities. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuations in which all significant inputs are observable in the market.

Level 3 – Valuation is modeled using significant inputs that are unobservable in the market. These unobservable inputs reflect the Company's own estimates of assumptions that market participants would use in pricing the asset or liability.

The Company’s valuation policy is determined by members of the Asset Management, Credit and Accounting departments. Whenever possible, the policy is to obtain quoted market prices in active markets to estimate fair values for recognition and disclosure purposes. Where quoted market prices in active markets are not available, fair values are estimated using discounted cash flow analyses, broker quotes and third party appraisals of collateral and/or other valuation techniques. These techniques are significantly affected by certain of the Company’s assumptions, including discount rates and estimates of future cash flows. Potential taxes and other transaction costs are not considered in estimating fair values. As the Company is responsible for determining fair value, an analysis is performed on prices obtained from third parties. Such analysis is performed by asset management and credit department personnel who are familiar with the Company’s investments in notes receivable and equity securities of venture companies. The analysis may include a periodic review of price fluctuations and validation of numbers obtained from a specific third party by reference to multiple representative sources.

Recent Accounting Pronouncements

Recent accounting pronouncements:

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2016-15 — Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 addresses specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments in this Update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. This guidance is effective for the Company beginning on January 1, 2018. The adoption of ASU 2016-15 did not have a material impact on its financial statements and disclosures.

In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The main objective of this Update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this Update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018. Management is currently evaluating the standard and expects the Update may potentially result in an increase in the allowance for credit losses given the change to estimated losses over the contractual life adjusted for expected prepayments.

In January 2016, the FASB issued Accounting Standards Update 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The new standard provides guidance related to accounting for equity investments and financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. ASU 2016-01, among other things, (i) requires equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income, (ii) simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment, (iii) eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet, (iv) requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, and (v) requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements. ASU 2016-01 is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. This guidance is effective for the Company beginning on January 1, 2018. The adoption of ASU 2016-01 did have an impact on its financial statements and disclosures.

The Company’s investment securities registered for public sale with readily determinable fair values are measured at fair value with any changes in fair value recognized in the Company's results of operations. The Company elected to record equity investments without readily determinable fair values at cost, less impairment, and adjusted for changes in observable prices. Any changes in the basis of these equity investments are reported in current earnings.

In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. On July 9, 2015, the FASB approved the deferral of the effective date of ASU 2014-09 by one year and in August 2015, issued Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. This guidance is effective for the Company beginning on January 1, 2018. Management’s evaluation of the impact of such adoption on the financial statements of the Fund indicated that such impact was immaterial as the new revenue guideline does not affect revenues from leases and loans, which comprise the majority of the Company’s revenues since leases and loans are not included within the scope of Topic 606.  

XML

Notes Receivable, Net (Tables)

6 Months Ended

Jun. 30, 2018

Accounts, Notes, Loans and Financing Receivable [Line Items]

Minimum Future Payments Receivable

As of June 30, 2018, the minimum future payments receivable are as follows (in thousands):

Six months ending December 31, 2018	$	1,186
Year ending December 31, 2019		1,758
2020		673
2021		187
		3,804
Less: portion representing unearned interest income, net		(591)
		3,213
Unamortized discount on warrants received		(98)
Unamortized initial direct costs		10
Notes receivable, net	$	3,125

Notes Receivable A [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Schedule of Notes Receivable on Non-Accrual Status

At June 30, 2018, the Company had no notes receivable on non-accrual status. As of December 31, 2017, four (Notes A and C) of the Company’s notes receivable were on non-accrual status. Details are as follows, in thousands, except for the number of notes receivable and the annual interest rate:

	Notes receivable A
	December 31, 2017
Number of notes		3
Net investment value	$	33
Annual interest rate		18.00%
Fair value adjustments	$	33
Fair value amount	$	-
Interest income not recorded relative to original terms	$	16

Notes Receivable C [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Schedule of Notes Receivable on Non-Accrual Status

	Note receivable C
	Non-accrual
	December 31, 2017
Number of notes		1
Net investment value	$	17
Annual interest rate		15.88%
Fair value adjustments	$	-
Fair value amount	$	17
Interest income not recorded relative to original terms	$	7

XML

Allowance for Credit Losses (Tables)

6 Months Ended

Jun. 30, 2018

Allowance for Credit Losses [Abstract]

Activity in Allowance for Doubtful Accounts

The Company’s allowance for credit losses are as follows (in thousands):

	Valuation Adjustments - Notes Receivable
Balance December 31, 2016	$	717
Note receivable disposal		(611)
Reversal of provision for credit losses		(73)
Balance December 31, 2017		33
Reversal of provision for credit losses		(33)
Balance June 30, 2018	$	-

Recorded Investment in Financing Receivables

The Company’s allowance for credit losses and its recorded investment in notes receivable as of December 31, 2017 were as follows (in thousands):

December 31, 2017		Notes Receivable
Allowance for credit losses:
Ending balance	$	33
Ending balance: individually evaluated for impairment	$	33
Ending balance: collectively evaluated for impairment	$	-
Financing receivables:
Ending balance	$	3,054
Ending balance: individually evaluated for impairment	$	3,054
Ending balance: collectively evaluated for impairment	$	-

Financing Receivables by Credit Quality Indicator and by Class

At June 30, 2018 and December 31, 2017, the Company’s notes receivables by credit quality indicator and by class of financing receivables are as follows (in thousands):

		Notes Receivable
	June 30, 2018		December 31, 2017
Pass	$	3,015	$	2,547
Special mention		8		392
Substandard		102		115
Doubtful		-		-
Total	$	3,125	$	3,054

Schedule of Impaired Loans

As of December 31, 2017, the Company’s impaired investment in financing receivables were as follows (in thousands):

	Impaired Investment in Financing Receivables
December 31, 2017	Recorded Investment		Unpaid Principal Balance		Related Allowance		Average Recorded Investment		Interest Income Recognized
With no related allowance recorded
Notes receivable	$	-	$	-	$	-	$	-	$	-
With an allowance recorded
Notes receivable		33		33		33		70		-
Total	$	33	$	33	$	33	$	70	$	-

Net Investment in Financing Receivables by Age

At June 30, 2018 and December 31, 2017, investment in financing receivables is aged as follows (in thousands):

June 30, 2018		31-60 Days Past Due		61-90 Days Past Due		Greater Than 90 Days		Total Past Due		Current		Total Financing Receivables		Recorded Investment>90 Days and Accruing
Notes receivable	$	-	$	-	$	-	$	-	$	3,125	$	3,125	$	-
Total	$	-	$	-	$	-	$	-	$	3,125	$	3,125	$	-

December 31, 2017		31-60 Days Past Due		61-90 Days Past Due		Greater Than 90 Days		Total Past Due		Current		Total Financing Receivables		Recorded Investment>90 Days and Accruing
Notes receivable	$	-	$	-	$	-	$	-	$	3,054	$	3,054	$	-
Total	$	-	$	-	$	-	$	-	$	3,054	$	3,054	$	-

XML

Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2018

Related Party Transactions [Abstract]

Managing Member and/or Affiliates Earned Commissions and Billed for Reimbursements Pursuant to Operating Agreement

During the three and six months ended June 30, 2018 and 2017, the Managing Member and/or affiliates earned commissions and fees, and billed for reimbursements of costs and expenses pursuant to the Operating Agreement as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Administrative costs reimbursed to Managing Member and/or affiliates	$	32	$	63	$	76	$	135
Asset management fees to Managing Member		12		14		25		32
Acquisition costs and note origination fees paid to Managing Member		6		41		33		105
	$	50	$	118	$	134	$	272

XML

Members' Capital (Tables)

6 Months Ended

Jun. 30, 2018

Members' Capital [Abstract]

Distributions to Other Members

Distributions to the Other Members for the three and six months ended June 30, 2018 and 2017 are as follows (in thousands, except as to Units and per Unit data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Distributions declared	$	346	$	444	$	787	$	888
Weighted average number of Units outstanding		1,612,396		1,615,475		1,612,396		1,616,311
Weighted average distributions per Unit	$	0.21	$	0.27	$	0.49	$	0.55

XML

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2018

Fair Value Measurement of Impaired Assets and Liabilities Measured at Fair Value on Non-Recurring Basis

The following table presents the fair value measurement of impaired assets measured at fair value on a non-recurring basis and the level within the hierarchy in which the fair value measurements fall at December 31, 2017 (in thousands):

	December 31, 2017		Level 1 Estimated Fair Value		Level 2 Estimated Fair Value		Level 3 Estimated Fair Value
Impaired investment securities	$	278	$	-	$	-	$	278

Summary of Valuation Techniques and Significant Unobservable Inputs

The following tables summarize the valuation techniques and significant unobservable inputs used for the Company’s recurring and non-recurring fair value calculation categorized as Level 3 in the fair value hierarchy at June 30, 2018 and December 31, 2017:

June 30, 2018
	Valuation	Valuation	Unobservable	Range of
Name	Frequency	Technique	Inputs	Input Values
Warrants	Recurring	Black-Scholes formulation	Stock price	$0.00 - $14.75
			Exercise price	$0.01 - $25.76
			Time to maturity (in years)	2.49 - 14.38
			Risk-free interest rate	2.58% - 2.88%
			Annualized volatility	25.13% - 292.22%
December 31, 2017
	Valuation	Valuation	Unobservable	Range of
Name	Frequency	Technique	Inputs	Input Values
Warrants	Recurring	Black-Scholes formulation	Stock price	$0.00 - $14.75
			Exercise price	$0.01 - $25.76
			Time to maturity (in years)	2.99 - 14.88
			Risk-free interest rate	1.98% - 2.49%
			Annualized volatility	27.78% - 83.30%
Impaired Investment Securities	Non-recurring	Market Approach	Qualitative and quantitative information (Investee Management)	Not Applicable

Estimated Fair Values of Financial Instruments

The following tables present estimated fair values of the Company’s financial instruments in accordance with the guidance provided by the Financial Instruments Topic of the FASB Accounting Standards Codificationat June 30, 2018 and December 31, 2017 (in thousands):

	June 30, 2018
	Carrying Amount		Level 1		Level 2		Level 3		Total
Financial assets:
Cash and cash equivalents	$	357	$	357	$	-	$	-	$	357
Notes receivable, net		3,125		-		-		3,253		3,253
Investment in securities		176		176		-		-		176
Warrants		542		-		-		542		542
	December 31, 2017
	Carrying Amount		Level 1		Level 2		Level 3		Total
Financial assets:
Cash and cash equivalents	$	1,255	$	1,255	$	-	$	-	$	1,255
Notes receivable, net		3,021		-		-		3,009		3,009
Warrants		489		-		-		489		489

Warrant [Member]

Fair Value of Warrants and Investment Securities Measured on a Recurring Basis

The fair value of warrants that were accounted for on a recurring basis as of the three and six months ended June 30, 2018 and 2017 and classified as level 3 are as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
Fair value of warrants at beginning of period	$	521	$	510	$	489	$	481
Fair value of new warrants, recorded during the year   (included as a discount on notes receivable)		12		-		34		-
Unrealized gain (loss) on fair value adjustment for warrants		9		(2)		19		27
Fair value of warrants at end of period	$	542	$	508	$	542	$	508

Equity Securities [Member]

Fair Value of Warrants and Investment Securities Measured on a Recurring Basis

The fair value of investment securities that were accounted for on a recurring basis as of the three and six months ended June 30, 2018 and classified as Level 1 are as follows (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2018		2018
Fair value of securities at beginning of period	$	218	$	92
Unrealized (loss) gain on fair value of securities		(42)		84
Fair value of investment securities at end of period	$	176	$	176

XML

Organization and Limited Liability Company Matters (Narrative) (Details) - USD ($)	6 Months Ended	79 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Dec. 31, 2011
Organization and Limited Liability Company Matters [Abstract]
Business activities, description	providing financing for the acquisition of equipment and other goods and services used by emerging growth companies and established privately held companies without publicly traded securities
Business formation date	Dec. 08, 2011
Business formation State	California
Contributions of capital, initial			$ 500
Capital contribution		$ 16,200,000
Units issued	1,612,396	1,612,396
Units outstanding	1,612,396	1,612,396

XML

Summary of Significant Accounting Policies (Narrative) (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($) segment	Jun. 30, 2017 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Mar. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Investments in equity securities	$ 341,000		$ 341,000			$ 243,000
Unrealized (loss) gain on fair value adjustment for investment in securities	(43,000)		98,000
Warrants, fair value	542,000	$ 508,000	542,000	$ 508,000	$ 521,000	$ 489,000	$ 510,000	$ 481,000
Unrealized gain (loss) on fair value adjustment for warrants	9,000	$ (2,000)	$ 19,000	27,000
Gain on sales or dispositions of investment in securities				$ 1,000
North America [Member] | Operating Revenue [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of operating segments | segment			1
Number of reportable segments | segment			1
Percentage of operating revenue from the customers domiciled in North America			100.00%
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Required assets value of financial institutions for cash deposits			$ 10,000,000,000
Accounts receivable, period for non-accrual status			90 days
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
U.S. Treasury instruments maturity period			90 days
Cash deposits, insured amount	$ 250,000		$ 250,000
Accounts receivable, period for review of impairment			90 days

XML

Notes Receivable, Net (Narrative) (Details) - contract	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Financing Receivable, Recorded Investment, Past Due [Line Items]
Number of notes receivables on non-accrual status		4
Notes receivable, maturity date description	The notes are secured by the equipment financed and have maturity dates ranging from 2018 through 2021.
Minimum [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Terms of the notes receivable	3 months
Notes receivable, interest rate	4.15%
Maximum [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Terms of the notes receivable	84 months
Notes receivable, interest rate	18.06%

XML

Notes Receivable, Net (Schedule of Notes Receivable on Non-Accrual Status) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($) contract
Financing Receivable, Modifications [Line Items]
Number of notes | contract	4
Notes Receivable A [Member]
Financing Receivable, Modifications [Line Items]
Number of notes | contract	3
Net investment value	$ 33
Annual interest rate	18.00%
Fair value adjustments	$ 33
Interest income not recorded relative to original terms	$ 16
Notes Receivable C [Member]
Financing Receivable, Modifications [Line Items]
Number of notes | contract	1
Net investment value	$ 17
Annual interest rate	15.88%
Fair value amount	$ 17
Interest income not recorded relative to original terms	$ 7

XML

Notes Receivable, Net (Minimum Future Payments Receivable) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Notes Receivable, Net [Abstract]
Six months ending December 31, 2018	$ 1,186
Year ending December 31, 2019	1,758
2020	673
2021	187
Notes receivable, gross	3,804
Less: portion representing unearned interest income, net	(591)
Notes Receivable before accretion expense and unamortized initial direct costs	3,213
Unamortized discount on warrants received	(98)
Unamortized initial direct costs	10
Notes receivable, net	$ 3,125	$ 3,021

XML

Allowance for Credit Losses (Activity in Allowance for Doubtful Accounts) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for credit losses	$ 9	$ 24	$ 33	$ 24
Valuation Adjustments on Financing Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Beginning Balance			33	$ 717	$ 717
Notes receivable disposal					(611)
Provision for credit losses			33		(73)
Ending Balance					$ 33

XML

Allowance for Credit Losses (Recorded Investment in Financing Receivables) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Financing receivables:
Notes receivable unamortized initial direct cost	$ 10
Notes Receivable [Member]
Allowances for credit losses:
Ending balance		$ 33
Ending balance: individually evaluated for impairment		33
Ending balance: collectively evaluated for impairment
Financing receivables:
Ending balance		3,054
Ending balance: individually evaluated for impairment		3,054
Ending balance: collectively evaluated for impairment

XML

Allowance for Credit Losses (Financing Receivables by Credit Quality Indicator and by Class) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Financing Receivable, Recorded Investment [Line Items]
Notes receivable	$ 3,125	$ 3,054
Pass [Member]
Financing Receivable, Recorded Investment [Line Items]
Notes receivable	3,015	2,547
Special Mention [Member]
Financing Receivable, Recorded Investment [Line Items]
Notes receivable	8	392
Substandard [Member]
Financing Receivable, Recorded Investment [Line Items]
Notes receivable	$ 102	$ 115

XML

Allowance for Credit Losses (Schedule of Impaired Loans) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($)
Allowance for Credit Losses [Abstract]
Notes receivable, With no allowance recorded, Recorded investment
Notes receivable, With no allowance recorded, Unpaid principal balance
Notes receivable, With no allowance recorded, Average recorded investment
Notes receivable, With no allowance recorded, Interest income recognized
Notes receivable, With an allowance recorded, Recorded investment	33
Notes receivable, With an allowance recorded, Unpaid principal balance	33
Notes receivable, With an allowance recorded, Related allowance	33
Notes receivable, With an allowance recorded, Average recorded investment	70
Notes receivable, With an allowance recorded, Interest income recognized
Recorded investment, Total	33
Unpaid principal balance, Total	33
Average recorded investment, Total	70
Interest income recognized, Total

XML

Allowance for Credit Losses (Net Investment in Financing Receivables by Age) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Current	3,125	$ 3,054
Total financing receivables	3,125	3,054
Recorded Investment > 90 Days and Accruing
Financing Receivables 31-60 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Financing Receivables 61-90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Greater Than 90 Days [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Notes Receivable [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Current	3,125	3,054
Total financing receivables	3,125	3,054
Recorded Investment > 90 Days and Accruing
Notes Receivable [Member] | Financing Receivables 31-60 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Notes Receivable [Member] | Financing Receivables 61-90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due
Notes Receivable [Member] | Greater Than 90 Days [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due

XML

Related Party Transactions (Managing Member and/or Affiliates Earned Commissions and Billed for Reimbursements Pursuant to Operating Agreement (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Related Party Transactions [Abstract]
Administrative costs reimbursed to Managing Member and/or affiliates	$ 32	$ 63	$ 76	$ 135
Asset management fees to Managing Member	12	14	25	32
Acquisition costs and note origination fees paid to Managing Member	6	41	33	105
Related party transaction, total	$ 50	$ 118	$ 134	$ 272

XML

Commitments (Narrative) (Details) $ in Millions	Jun. 30, 2018 USD ($)
Commitments [Abstract]
Commitments to fund investments in notes receivable	$ 1.2

XML

Members' Capital (Narrative) (Details) - shares	Jun. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Members Capital Account [Line Items]
Members capital account, Units issued	1,612,396
Members capital account, Units outstanding	1,612,396
Members capital account, Units authorized	7,500,000	7,500,000
Other Members [Member]
Other Members Capital Account [Line Items]
Members capital account, Units issued	1,612,396	1,612,396
Members capital account, Units outstanding	1,612,396	1,612,396	1,618,296
Initial Member [Member]
Other Members Capital Account [Line Items]
Members capital account, Units issued	50	50

XML

Members' Capital (Distributions to Other Members) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Members' Capital [Abstract]
Distributions declared	$ 346	$ 444	$ 787	$ 888	$ 1,774
Weighted average number of Units outstanding	1,612,396	1,615,475	1,612,396	1,616,311
Weighted average distributions per Unit	$ 0.21	$ 0.27	$ 0.49	$ 0.55	$ 1.10

XML

Fair Value Measurements (Narrative) (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016
Fair Value Measurements [Abstract]
Warrants, fair value	$ 542	$ 521	$ 489	$ 508	$ 510	$ 481
Fair value measurement, valuation techniques used	Black-Scholes formulation

XML

Fair Value Measurements (Warrants Accounted for on A Recuuring Basis and Classified as Level 3) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Fair Value Measurements [Abstract]
Fair value of warrants at beginning of period	$ 521	$ 510	$ 489	$ 481
Fair value of new warrants, recorded during the year (included as a discount on notes receivable)	12		34
Unrealized (loss) gain on fair value adjustment for warrants	9	(2)	19	27
Fair value of warrants at end of period	$ 542	$ 508	$ 542	$ 508

XML

Fair Value Measurements (Fair Value Measurement of Impaired Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis) (Details) $ in Thousands	Dec. 31, 2017 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired notes receivable, net	$ 278
Level 3 Estimated Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired notes receivable, net	$ 278

XML

Fair Value Measurements (Summary of Valuation Techniques and Significant Unobservable Inputs) (Details) - Level 3 Estimated Fair Value [Member] - Recurring [Member] - Black-Scholes Formulation [Member] - Warrant [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock price	$ 0.00	$ 0.00
Exercise price	$ 0.01	$ 0.01
Time to maturity (in years)	2 years 5 months 27 days	2 years 11 months 27 days
Risk-free interest rate	2.58%	1.98%
Annualized volatility	25.13%	27.78%
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock price	$ 14.75	$ 14.75
Exercise price	$ 25.76	$ 25.76
Time to maturity (in years)	14 years 4 months 17 days	14 years 10 months 17 days
Risk-free interest rate	2.88%	2.49%
Annualized volatility	292.22%	83.30%

XML

Fair Value Measurements (Fair Value of Investment Securities Accounted for on a Recurring Basis) (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Unrealized (loss) gain on fair value of securities	$ (43)	$ 98
Level 1 Estimated Fair Value [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of securities at beginning of period	218	92
Unrealized (loss) gain on fair value of securities	(42)	84
Fair value of investment securities at end of period	$ 176	$ 176

XML

Fair Value Measurements (Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016
Financial assets:
Investment in securities	$ 341		$ 243
Warrants	542	$ 521	489	$ 508	$ 510	$ 481
Carrying Amount [Member]
Financial assets:
Cash and cash equivalents	357		1,255
Notes receivable, net	3,125		3,021
Investment in securities	176
Warrants	542		489
Estimated Fair Value [Member]
Financial assets:
Cash and cash equivalents	357		1,255
Notes receivable, net	3,253		3,009
Investment in securities	176
Warrants	542		489
Estimated Fair Value [Member] | Level 1 Estimated Fair Value [Member]
Financial assets:
Cash and cash equivalents	357		1,255
Investment in securities	176
Estimated Fair Value [Member] | Level 2 Estimated Fair Value [Member]
Financial assets:
Cash and cash equivalents
Notes receivable, net
Investment in securities
Warrants
Estimated Fair Value [Member] | Level 3 Estimated Fair Value [Member]
Financial assets:
Notes receivable, net	3,253		3,009
Warrants	$ 542		$ 489